Valsartan Cancer Lawsuits & Contamination Recalls - The Lyon Firm
« Back to Blog

Valsartan Cancer Lawsuits & Contamination Recalls

Product Liability Lawyer and Drug Injury Attorney reviews valsartan cancer lawsuits for plaintiffs nationwide


The U.S. Food and Drug Administration (FDA) has continued valsartan recall notices, and warns of cancer risks associated with the drug. Independent lab tests have identified popular blood pressure drugs available to consumers are contaminated a chemical considered to be a possible carcinogen.

There have been numerous recalls for hypertension drugs that contain valsartan. Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals have recalled several drug lots. The FDA is evaluating any drug containing valsartan to determine if they contain NDMA, including:

  • Valsartan
  • Losartan—Sandoz and Camber Pharmaceutical
  • Telmisartan
  • Olmesartan
  • Irbesartan—recalled by ScieGen Pharmaceuticals Inc. and bottled and labeled as Westminster Pharmaceuticals and Golden State Medical Supply, Inc.
  • Eprosartan
  • Candesartan
  • Azilsartan
  • Amlopidine
  • Hydrochlorothiazide

Joe Lyon is an experienced product liability attorney and drug injury lawyer investigating cancer risks for plaintiffs nationwide and Valsartan cancer lawsuits.

The Lyon Firm has experience engaging pharmaceutical companies in drug contamination cases.


Valsartan Cancer Risk & Drug Recall

The FDA is investigating impurities in valsartan drugs, from N-Nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA), both of which can cause harm at very low levels. To give you an idea of the risks, NDEA is used to make rocket fuel, and it is also a byproduct of pesticide manufacturing.

Valsartan is a hypertension medication used to control high blood pressure as a Angiotensin Receptor Blockers (ARBs). The drugs block a natural hormone called angiotensin II, which works to narrow your arteries, increasing your blood pressure.


Legal Action: Valsartan Cancer Lawsuits

Contaminated drugs may be recalled after they have already caused damage and injured patients, and typically because pharmaceutical companies fail to properly test their product before released to the public.

Following injuries, companies may be held liable for injuries in valsartan cancer lawsuits and other drug recall lawsuits. Drug manufacturers have a responsibility test and protect consumers, and should they fail, they may face personal injury and product liability claims.

If you or a loved one has suffered a valsartan-related injury, and have questions about the legal remedies available to improve quality of life and medical care, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, and he will help you answer critical questions regarding valsartan cancer lawsuits.

Contact us today.